Nationwide Fund Advisors’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-57,776
| Closed | -$1.44M | – | 1955 |
|
|
2017
Q3 | $1.44M | Sell |
57,776
-1,648
| -3% | -$41K | 0.01% | 1600 |
|
|
2017
Q2 | $1.15M | Buy |
59,424
+7,583
| +15% | +$147K | ﹤0.01% | 1709 |
|
|
2017
Q1 | $957K | Buy |
51,841
+29,290
| +130% | +$541K | ﹤0.01% | 1771 |
|
|
2016
Q4 | $427K | Sell |
22,551
-793
| -3% | -$15K | ﹤0.01% | 2257 |
|
|
2016
Q3 | $522K | Hold |
23,344
| – | – | ﹤0.01% | 2162 |
|
|
2016
Q2 | $416K | Buy |
23,344
+862
| +4% | +$15.4K | ﹤0.01% | 2242 |
|
|
2016
Q1 | $307K | Sell |
22,482
-675
| -3% | -$9.22K | ﹤0.01% | 2324 |
|
|
2015
Q4 | $447K | Buy |
23,157
+505
| +2% | +$9.75K | ﹤0.01% | 2164 |
|
|
2015
Q3 | $459K | Hold |
22,652
| – | – | ﹤0.01% | 2164 |
|
|
2015
Q2 | $751K | Buy |
22,652
+5,369
| +31% | +$178K | ﹤0.01% | 2029 |
|
|
2015
Q1 | $414K | Buy |
17,283
+1,388
| +9% | +$33.2K | ﹤0.01% | 2331 |
|
|
2014
Q4 | $195K | Sell |
15,895
-492
| -3% | -$6.04K | ﹤0.01% | 2650 |
|
|
2014
Q3 | $148K | Buy |
16,387
+2
| +0% | +$18 | ﹤0.01% | 2840 |
|
|
2014
Q2 | $192K | Buy |
16,385
+10,554
| +181% | +$124K | ﹤0.01% | 2772 |
|
|
2014
Q1 | $124K | Buy |
+5,831
| New | +$124K | ﹤0.01% | 2674 |
|